Retreatment with Brentuximab Vedotin for CD30+ Cutaneous T-cell Lymphoma and Lymphomatoid Papulosis
Skinmed
.
2024 Dec 31;22(6):489-490.
eCollection 2024.
Authors
David M Weiner
1
,
Daniel J Lewis
2
Affiliations
1
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; David.Weiner@pennmedicine.upenn.edu.
2
Department of Dermatology at the Hospital of the University of Pennsylvania, Philadelphia, PA.
PMID:
39748590
No abstract available